<DOC>
	<DOC>NCT03039855</DOC>
	<brief_summary>To evaluate the safety and performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.</brief_summary>
	<brief_title>Tiaraâ„¢ Transcatheter Mitral Valve Replacement Study</brief_title>
	<detailed_description>The TIARA-II study is an international, multicenter, single-arm, prospective, safety and performance clinical study.</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Severe mitral regurgitation High surgical risk for open mitral valve surgery Subject meets anatomical eligibility criteria Deemed too frail by objective frailty assessments Previous cardiac procedures: any mitral valve replacement surgery and cardiac transplant Unsuitable cardiac structure Clinically significant untreated Coronary Artery Disease (CAD) Subjects on chronic dialysis Pregnant or planning pregnancy within next 12 months Documented bleeding or coagulation disorders Active infections requiring antibiotic therapy Subjects with a life expectancy less than 12 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Mitral</keyword>
	<keyword>Regurgitation</keyword>
	<keyword>Heart valve</keyword>
	<keyword>Transcatheter</keyword>
	<keyword>Transapical</keyword>
	<keyword>Functional</keyword>
	<keyword>Degenerative</keyword>
	<keyword>TMVR</keyword>
</DOC>